Skip to main content
Signal8

Johnson Craig A

SEC insider (Form 3/4/5 filer). CIK 0001370348. Director at Aurinia Pharmaceuticals Inc. (AUPH) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in EDMONTON.

Companies Johnson Craig A has filed insider reports for

  • Aurinia Pharmaceuticals Inc. (AUPH): Director
  • HERON THERAPEUTICS, INC. /DE/ (HRTX): Director
Johnson Craig A profile photo

Johnson Craig A

CIK: 0001370348

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (85.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (14.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Aurinia Pharmaceuticals Inc. logo
AUPH

Aurinia Pharmaceuticals Inc.

Director
HERON THERAPEUTICS, INC. /DE/ logo
HRTX

HERON THERAPEUTICS, INC. /DE/

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Aurinia Pharmaceuticals Inc. logo
    AUPH

    Aurinia Pharmaceuticals Inc.

    Jun 4, 2026
    Award

    Director Stock Option (right to buy)

    Direct
    23.9K shares-
  • HERON THERAPEUTICS, INC. /DE/ logo
    HRTX

    HERON THERAPEUTICS, INC. /DE/

    Jan 30, 2026
    Award
    Direct
    54K shares-
  • Aurinia Pharmaceuticals Inc. logo
    AUPH

    Aurinia Pharmaceuticals Inc.

    Nov 21, 2025
    Tax Payment
    Direct
    6K shares at avg. $15.68$95K
  • Aurinia Pharmaceuticals Inc. logo
    AUPH

    Aurinia Pharmaceuticals Inc.

    May 16, 2025
    Award

    Director Stock Option (right to buy)

    Direct
    37.5K shares-
  • HERON THERAPEUTICS, INC. /DE/ logo
    HRTX

    HERON THERAPEUTICS, INC. /DE/

    Jan 31, 2025
    Award
    Direct
    18K shares-
  • HERON THERAPEUTICS, INC. /DE/ logo
    HRTX

    HERON THERAPEUTICS, INC. /DE/

    Jan 30, 2025
    Award
    Direct
    18K shares-
  • Aurinia Pharmaceuticals Inc. logo
    AUPH

    Aurinia Pharmaceuticals Inc.

    Nov 21, 2024
    Award
    Direct
    20.6K shares-

1-7 of 7